Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: PAL who wrote (3168)	12/6/1997 12:10:00 AM
From: billkirn	Read Replies (1) \| Respond to of 6136

I think Peter Johnson is not a research type character. I think he is all business. He has been recognized as being one of the best business biotech managers in the industry. His negotiating and management skills are legendary. His ability to obtain Viracept for very little in return, some kind of coordinates for the cold virus I think, is a tribute to his bsuiness skills. This guy wants to build a real Pharm. company and he will do it. Bill